Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4K Sell
385
-910
-70% -$40.7K ﹤0.01% 822
2026
Q1
$62.4K Buy
1,295
+21
+2% +$979 0.01% 480
2025
Q4
$61.7K Hold
1,274
0.01% 509
2025
Q3
$60.1K Buy
1,274
+18
+1% +$869 ﹤0.01% 516
2025
Q2
$60.7K Hold
1,256
0.01% 522
2025
Q1
$69.7K Hold
1,256
0.01% 485
2024
Q4
$60.6K Hold
1,256
0.01% 502
2024
Q3
$60.1K Sell
1,256
-5,131
-80% -$277K 0.01% 491
2024
Q2
$310K Buy
6,387
+6,353
+18,685% +$306K 0.04% 179
2024
Q1
$1.65K Buy
+34
New +$1.66K ﹤0.01% 764

Other funds holding SNY

LRI Investments's SNY Position: Q2 2026 in Review

LRI Investments reduced its Sanofi (SNY) stake by 70% in Q2 2026, selling an estimated $40.7K and leaving 385 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #822.

LRI Investments first reported a position in SNY in Q1 2024 and has held it in 10 quarters since. The position peaked at $310K in Q2 2024. 108 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • LRI Investments held 385 shares of Sanofi worth $16.4K as of Q2 2026.
  • LRI Investments sold 910 Sanofi shares in Q2 2026, an estimated $40.7K.
  • Sanofi made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #822 holding.
  • LRI Investments first reported a position in Sanofi in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Sanofi position peaked at $310K in Q2 2024.
  • 108 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.